SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-040247
Filing Date
2024-04-02
Accepted
2024-04-02 16:35:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A crbp_defa14a_2024_04_02.htm DEFA14A 11840
2 GRAPHIC img110654685_0.jpg GRAPHIC 69645
3 GRAPHIC img110654685_1.jpg GRAPHIC 45044
  Complete submission text file 0000950170-24-040247.txt   171148
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37348 | Film No.: 24814889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)